Bank of Montreal’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-236,000
Closed -$3.55M 3967
2021
Q2
$3.55M Sell
236,000
-134
-0.1% -$2.06K ﹤0.01% 1776
2021
Q1
$3.9M Sell
236,134
-605
-0.3% -$10.8K ﹤0.01% 1464
2020
Q4
$3.8M Buy
236,739
+517
+0.2% +$7.3K ﹤0.01% 1529
2020
Q3
$2.92M Buy
236,222
+200,839
+568% +$2.59M ﹤0.01% 1491
2020
Q2
$374K Buy
+35,383
New +$479K ﹤0.01% 2416
2020
Q1
Sell
-417
Closed -$11K 4786
2019
Q4
$11K Buy
+417
New +$7.42K ﹤0.01% 4549

Other funds holding XGN

Bank of Montreal's XGN Position: Q3 2021 in Review

Bank of Montreal sold out of Exagen (XGN) in Q3 2021, closing a stake of 236,000 shares — an estimated $3.55M sold.

Bank of Montreal first reported a position in XGN in Q4 2019 and held it in 6 quarters. The position peaked at $3.9M in Q1 2021. 53 funds tracked by Wall St. Rank hold XGN as of Q3 2021.

  • Bank of Montreal reported no remaining Exagen position as of Q3 2021 after selling out during the quarter.
  • Bank of Montreal sold 236,000 Exagen shares in Q3 2021, an estimated $3.55M.
  • Bank of Montreal first reported a position in Exagen in Q4 2019 and held it in 6 quarters.
  • Bank of Montreal's Exagen position peaked at $3.9M in Q1 2021.
  • 53 funds tracked by Wall St. Rank held Exagen as of Q3 2021.

Based on Bank of Montreal's 13F filing for Q3 2021, filed 12 Nov 2021.